Work

Supplementary Table S1 from Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Table 1. Representativeness of Study Participants

DOI: 10.1158/1078-0432.29568305

Authors: Nicole C. Schmitt, William A. Stokes, James E. Bates, Brendan L.C. Kinney, Jill Remick, Mark W. McDonald, Soumon Rudra, Madison Steininger, Mosope Oyewole, Mihir R. Patel, Azeem S. Kaka, Jennifer H. Gross, Jeffrey Switchenko, Conor E. Steuer, Dong M. Shin, Nabil F. Saba

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4412417485

Cites:

Cited by: 1

Related to: 10